Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
1,317,463
-
Share change
-
-87,193
-
Total reported value
-
$10,909,140
-
Put/Call ratio
-
39%
-
Price per share
-
$8.28
-
Number of holders
-
17
-
Value change
-
-$686,993
-
Number of buys
-
11
-
Number of sells
-
11
Institutional Holders of BRIACELL THERAPEUTICS CORP - COM NEW (BCTX) as of Q4 2021
As of 31 Dec 2021,
BRIACELL THERAPEUTICS CORP - COM NEW (BCTX) was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,317,463 shares.
The largest 10 holders included
Lynwood Capital Management Inc., VOLORIDGE INVESTMENT MANAGEMENT, LLC, Redmond Asset Management, LLC, Summit Trail Advisors, LLC, NATIONAL BANK OF CANADA /FI/, Virtu Financial LLC, Apollon Wealth Management, LLC, Insight Advisors, LLC/ PA, Eqis Capital Management, Inc., and Total Clarity Wealth Management, Inc..
This page lists
17
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.